Search results
Is Invitae Stock a Buy Now?
Motley Fool via Yahoo Finance· 4 months agoInvitae (NYSE: NVTA) has grown revenue over time, but the genetic testing specialist has failed to turn that into profit. Instead, the company burned...
Invitae Stock: Bull vs. Bear
Motley Fool· 1 year agoDown nearly 85% in 2022. That's the situation for Invitae (NYSE: NVTA) stock. There's no way to spin that as positive news. However, this steep sell-off...
Invitae Corp (NVTA) Reports Mixed Third Quarter 2023 Financial Results Amid Operational Adjustments
GuruFocus.com via Yahoo Finance· 7 months agoInvitae Corp (NYSE:NVTA) reported a 9% year-over-year revenue decrease to $121.2 million in Q3 2023,...
Great week for Invitae Corporation (NYSE:NVTA) institutional investors after losing 65% over the...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Significantly high institutional ownership implies Invitae's stock price is sensitive...
Could Invitae Stock Help You Retire a Millionaire?
Motley Fool· 2 years agoInvitae (NYSE: NVTA) is a small-cap stock with huge potential in the genetic testing market. The company makes money from providing testing services that...
Invitae Corporation (NYSE:NVTA) Stock's 27% Dive Might Signal An Opportunity But It Requires Some...
Simply Wall St. via Yahoo Finance· 1 year agoInvitae Corporation (NYSE:NVTA) shareholders that were waiting for something to happen have been...
Will Invitae (NVTA) Report Negative Q2 Earnings? What You Should Know
Zacks via Yahoo Finance· 2 years agoInvitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely...
Why Invitae Corporation Sank as Much as 25.5% This Week
Motley Fool· 2 years agoWhat happened Shares of Invitae Corporation (NYSE: NVTA) sank as much as 25.5% this week, according...
Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoInvitae (NVTA) delivered earnings and revenue surprises of 28.81% and 0.55%, respectively, for the...
Is Invitae in Danger of Running Out of Money?
Motley Fool· 2 years agoInvitae (NYSE: NVTA) is a genetic testing company that's in its early growth stages, so shareholders should expect to take on some risk with a stock like...